1. Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic‐pharmacodynamic analysis of cinacalcet. Issue 6 (25th April 2019) Authors: Chen, Ping; Sohn, Winnie; Narayanan, Adimoolam; Gisleskog, Per Olsson; Melhem, Murad Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 6(2019) Page Start: 1312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Pharmacokinetics and Pharmacodynamics of Etelcalcetide, a Novel Calcimimetic for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis. (13th March 2018) Authors: Wu, Benjamin; Melhem, Murad; Subramanian, Raju; Chen, Ping; Jaramilla Sloey, Bethlyn; Fouqueray, Bruno; Hock, M. Benjamin; Skiles, Gary L.; Chow, Andrew T.; Lee, Edward Journal: Journal of clinical pharmacology Issue: Volume 58:Number 6(2018) Page Start: 717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative analysis of PD‐1 target engagement of dostarlimab and pembrolizumab in advanced solid tumors using ex vivo IL‐2 stimulation data. (16th November 2022) Authors: Austin, Daren; Melhem, Murad; Gandhi, Yash; Lu, Sharon; Visser, Sandra Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 12:Number 1(2023) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetic–pharmacodynamic modelling of neutrophil response to G‐CSF in healthy subjects and patients with chemotherapy‐induced neutropenia. (20th February 2018) Authors: Melhem, Murad; Delor, Isabelle; Pérez‐Ruixo, Juan Jose; Harrold, John; Chow, Andrew; Wu, Liviawati; Jacqmin, Philippe Journal: British journal of clinical pharmacology Issue: Volume 84:Number 5(2018:Nov.) Page Start: 911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Population pharmacokinetics analysis of AMG 416, an allosteric activator of the calcium‐sensing receptor, in subjects with secondary hyperparathyroidism receiving hemodialysis. (18th February 2015) Authors: Chen, Ping; Melhem, Murad; Xiao, Jim; Kuchimanchi, Mita; Perez Ruixo, Juan Jose Journal: Journal of clinical pharmacology Issue: Volume 55:Number 6(2015:Jun.) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population pharmacokinetics and exposure–response of anti‐programmed cell death protein‐1 monoclonal antibody dostarlimab in advanced solid tumours. Issue 9 (28th April 2022) Authors: Melhem, Murad; Hanze, Eva; Lu, Sharon; Alskär, Oskar; Visser, Sandra; Gandhi, Yash Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 9(2022) Page Start: 4142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment. Issue 5 (12th January 2015) Authors: Shilbayeh, Sireen A.R.; Sy, Sherwin K.B.; Melhem, Murad; Zmeili, Rawan; Derendorf, Hartmut Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 5(2015:Sep./Oct.) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Receiver Operating Characteristic Analysis and Clinical Trial Simulation to Inform Dose Titration Decisions. (15th October 2018) Authors: Clements, John David; Perez Ruixo, Juan Jose; Gibbs, John P.; Doshi, Sameer; Perez Ruixo, Carlos; Melhem, Murad Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 7:Number 11(2018) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗